Company Information 

Bio2 is a medical device company developing and commercializing novel tissue engineering scaffolds for orthopedic applications. Bio2’s core technology, called cross-linked microstructure or CLM™, allows Bio2 to engineer and control pore morphology along with the bulk mechanical properties of materials resulting in a high porosity (50-90%) load bearing structure.

The Company is commercializing  two distinct products:  bio-inert and bio-active CLM scaffolds both of which use FDA approved materials.

CLM technology was developed by GEO2 Technologies, Inc. Bio2 has licensed CLM to develop and commercialize the technology in the medical device field.